Please wait while the formulary information is being retrieved.
Drug overview for NIZORAL PSORIASIS (salicylic acid):
Generic name: SALICYLIC ACID
Drug class:
Therapeutic class: Dermatological
Salicylic acid is a keratolytic agent.
Salicylic acid is used topically for its keratolytic effect in the management of acne and other skin conditions such as seborrheic dermatitis, psoriasis, and dandruff; the drug also is used topically for the removal of warts, corns, and calluses. Salicylic acid is not used systemically because of its severe irritating effect on GI mucosa and other tissues. (See the Salicylates General Statement 28:08.04.24.)
Generic name: SALICYLIC ACID
Drug class:
Therapeutic class: Dermatological
Salicylic acid is a keratolytic agent.
Salicylic acid is used topically for its keratolytic effect in the management of acne and other skin conditions such as seborrheic dermatitis, psoriasis, and dandruff; the drug also is used topically for the removal of warts, corns, and calluses. Salicylic acid is not used systemically because of its severe irritating effect on GI mucosa and other tissues. (See the Salicylates General Statement 28:08.04.24.)
DRUG IMAGES
- No Image Available
The following indications for NIZORAL PSORIASIS (salicylic acid) have been approved by the FDA:
Indications:
Dandruff
Psoriasis
Seborrheic dermatitis
Professional Synonyms:
Branny tetter
Dermatitis seborrheica
Dyssebacea
Dyssebacia
Pityriasis capitis
Pityriasis sicca
Pityriasis simplex
Scurf
Seborrhea corporis
Seborrhea furfuracea
Seborrhea sicca
Seborrheic eczema
Unna's disease
Indications:
Dandruff
Psoriasis
Seborrheic dermatitis
Professional Synonyms:
Branny tetter
Dermatitis seborrheica
Dyssebacea
Dyssebacia
Pityriasis capitis
Pityriasis sicca
Pityriasis simplex
Scurf
Seborrhea corporis
Seborrhea furfuracea
Seborrhea sicca
Seborrheic eczema
Unna's disease
The following dosing information is available for NIZORAL PSORIASIS (salicylic acid):
No enhanced Dosing information available for this drug.
Salicylic acid is applied topically to the skin as a cake, cream, gel, lotion, ointment, pledget, plaster, shampoo, solution, or suspension. Topical preparations of salicylic acid are for external use only. Contact with the eyes should be avoided; if contact occurs, the affected eye(s) should be washed thoroughly with water.
Prior to topical application, the affected area(s) to be treated should be cleansed and allowed to dry. Prior to removal of warts, corns, and calluses, the affected area may be soaked in warm water for 5 minutes. Salicylic acid is commercially available in various preparations, some of which are intended for self-medication; the manufacturer's product labeling should be consulted for complete directions regarding appropriate dosage and administration of specific products.
Prior to topical application, the affected area(s) to be treated should be cleansed and allowed to dry. Prior to removal of warts, corns, and calluses, the affected area may be soaked in warm water for 5 minutes. Salicylic acid is commercially available in various preparations, some of which are intended for self-medication; the manufacturer's product labeling should be consulted for complete directions regarding appropriate dosage and administration of specific products.
No dosing information available.
No generic dosing information available.
The following drug interaction information is available for NIZORAL PSORIASIS (salicylic acid):
There are 0 contraindications.
There are 0 severe interactions.
There are 0 moderate interactions.
The following contraindication information is available for NIZORAL PSORIASIS (salicylic acid):
Drug contraindication overview.
No enhanced Contraindications information available for this drug.
No enhanced Contraindications information available for this drug.
There are 2 contraindications.
Absolute contraindication.
Contraindication List |
---|
Aspirin exacerbated respiratory disease |
Hemolytic anemia from pyruvate kinase and g6PD deficiencies |
There are 0 severe contraindications.
There are 1 moderate contraindications.
Clinically significant contraindication, where the condition can be managed or treated before the drug may be given safely.
Moderate List |
---|
Peripheral vascular disease |
The following adverse reaction information is available for NIZORAL PSORIASIS (salicylic acid):
Adverse reaction overview.
No enhanced Common Adverse Effects information available for this drug.
No enhanced Common Adverse Effects information available for this drug.
There are 12 severe adverse reactions.
More Frequent | Less Frequent |
---|---|
None. | None. |
Rare/Very Rare |
---|
Anaphylaxis Burns Dyspnea Facial edema Hypersensitivity drug reaction Periorbital edema Pharyngeal edema Skin ulcer Superficial skin ulcer Syncope Throat constriction Urticaria |
There are 4 less severe adverse reactions.
More Frequent | Less Frequent |
---|---|
Stinging of skin |
Dry skin Skin irritation |
Rare/Very Rare |
---|
Pruritus of skin |
The following precautions are available for NIZORAL PSORIASIS (salicylic acid):
No enhanced Pediatric Use information available for this drug.
Contraindicated
Severe Precaution
Management or Monitoring Precaution
Contraindicated
None |
Severe Precaution
None |
Management or Monitoring Precaution
None |
There are no adequate and well-controlled studies of topical salicylic acid in pregnant women; the drug should be used during pregnancy only if the potential benefits justify the possible risks to the fetus.
Because of the potential for serious adverse reactions to salicylic acid in nursing infants, a decision should be made whether to discontinue nursing or the drug, taking into account the importance of the drug to the woman. If used in nursing women, the drug should not be applied to the chest area to avoid accidental contamination of the infant.
No enhanced Geriatric Use information available for this drug.
The following prioritized warning is available for NIZORAL PSORIASIS (salicylic acid):
No warning message for this drug.
No warning message for this drug.
The following icd codes are available for NIZORAL PSORIASIS (salicylic acid)'s list of indications:
Dandruff | |
L21.0 | Seborrhea capitis |
Psoriasis | |
L40 | Psoriasis |
L40.0 | Psoriasis vulgaris |
L40.1 | Generalized pustular psoriasis |
L40.2 | Acrodermatitis continua |
L40.3 | Pustulosis palmaris et plantaris |
L40.4 | Guttate psoriasis |
L40.5 | Arthropathic psoriasis |
L40.50 | Arthropathic psoriasis, unspecified |
L40.51 | Distal interphalangeal psoriatic arthropathy |
L40.52 | Psoriatic arthritis mutilans |
L40.53 | Psoriatic spondylitis |
L40.54 | Psoriatic juvenile arthropathy |
L40.59 | Other psoriatic arthropathy |
L40.8 | Other psoriasis |
L40.9 | Psoriasis, unspecified |
Seborrheic dermatitis | |
L21 | Seborrheic dermatitis |
L21.0 | Seborrhea capitis |
L21.1 | Seborrheic infantile dermatitis |
L21.8 | Other seborrheic dermatitis |
L21.9 | Seborrheic dermatitis, unspecified |
Formulary Reference Tool